Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
1 registered trial, newest registry update first. Showing only trials linked to LL-37.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Intratumoral Injections of LL37 for Melanoma NCT02225366 | LL-37 | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 4 | Nov 24, 2020 | Dec 9, 2021 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.
